Bojan Zarić

Lazertinib Versus Gefitinib as First-Line Treatment in Patients With <i>EGFR</i>-Mutated Advanced Non–Small-Cell Lung Cancer: Results From LASER301

Byoung Chul Cho, Myung‐Ju Ahn, Jin Hyoung Kang et al. · Journal of Clinical Oncology · 2023 · 137 citations · Full text

Medicine, Oncology, Pharmacology +15

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

Lowell L. Hart, Renata Ferrarotto, Zoran Andrić et al. · Advances in Therapy · 2020 · 125 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1)

Suresh S. Ramalingam, Glenwood Goss, Rafael Rosell et al. · Annals of Oncology · 2015 · 108 citations · Full text

Medicine, Oncology, Pharmacology +13

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia

Bojan Zarić, Ilija Andrijević, Jovan Matijašević et al. · Annals of Thoracic Medicine · 2014 · 60 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Differential Diagnosis of Tuberculous and Malignant Pleural Effusions: What is the Role of Adenosine Deaminase?

Bojan Zarić, Vesna Kuruc, Aleksandar Milovančev et al. · Lung · 2008 · 60 citations

Medicine, Internal Medicine, Pathology +16